Cargando…

Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival

The nuclear factor E2-related factor 2 (NRF2) signaling pathway is one of the most important cell defense pathways. However, it is unclear whether genetic variants in NRF2 signaling pathway genes are associated with the survival of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Rongbin, Qiu, Moqin, Cao, Ji, Zhou, Zihan, Wei, Yuying, Wen, Qiuping, Lin, Qiuling, Wei, Xiaoxia, Liang, Xiumei, Jiang, Yanji, Chen, Peiqin, Wei, Junjie, Zhan, Shicheng, Liu, Yingchun, Yu, Hongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647191/ https://www.ncbi.nlm.nih.gov/pubmed/38021150 http://dx.doi.org/10.7150/jca.88561

Ejemplares similares

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration
por: Long, Meiying, et al.
Publicado: (2022)

Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients
por: Huang, Qiongguang, et al.
Publicado: (2022)

A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population
por: Qiu, Moqin, et al.
Publicado: (2020)

A novel signature constructed by super-enhancer-related genes for the prediction of prognosis in hepatocellular carcinoma and associated with immune infiltration
por: Wei, Xueyan, et al.
Publicado: (2023)

Association between Single-Nucleotide Polymorphism in MicroRNA Target Site of DDB2 and Risk of Hepatocellular Carcinoma in a Southern Chinese Population
por: Qiu, Moqin, et al.
Publicado: (2020)

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation
por: Zhou, Zihan, et al.
Publicado: (2020)

Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study
por: Long, Meiying, et al.
Publicado: (2023)

Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis
por: Zhou, Zewen, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms in miR-122 Are Associated with the Risk of Hepatocellular Carcinoma in a Southern Chinese Population
por: Bei, Chunhua, et al.
Publicado: (2018)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Studies on the correlation between mutation and integration of HBV in hepatocellular carcinoma
por: Cui, Xiaofang, et al.
Publicado: (2020)

Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection
por: Zhang, Wei, et al.
Publicado: (2019)

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma
por: Liu, Youde, et al.
Publicado: (2020)

Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2017)

Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing
por: Zhang, Haikun, et al.
Publicado: (2020)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas
por: Wei, Yanyan, et al.
Publicado: (2019)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma
por: Wang, Qianqian, et al.
Publicado: (2016)

Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma
por: Huang, Dan-Ping, et al.
Publicado: (2021)

Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network
por: Nong, Shunqiang, et al.
Publicado: (2021)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
por: Hong, Ying-Fen, et al.
Publicado: (2017)

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma
por: Xue, Xiulan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vr20rqfj4ef33qts4s3ar9gdh1